It seems like U.S healthcare is more concerned about profits than patients these days. Now is the time to learn more about the latest legal battles patients face with conditions from head to toe and how to be your own best healthcare advocate, so you receive the care you deserve.
According to the Parmaceutical Business Review online, a study out of Washington University School of Medicine shows that non-steroidal anti-inflammatory drugs (NSAID) can increase liver damage in patients. Here are some details of the study:Using an experimental mouse model of the disorder, the researchers investigated the effects of a non-steroidal anti-inflammatory drug (NSAID) on liver...
Last week the Food and Drug Administration (FDA) recalled 11 million bottles of acetaminophen, sold as store brands at CVS Pharmacy, Wal-Mart and more than 120 other retailers nationwide. The 500 mg caplets made by Perrigo Corp. of Michigan were pulled from the shelves because of the possibility that they might contain metal fragments. A story out of the Montgomery Advertiser reports further...
A number of drugs which are often used to treat osteoporosis and cancer patients are believed to cause a terrible jaw disease called osteonecrosis of the jaw or "dead jaw." Fosamax, Actonel, Boniva, Skelid, Adedia, Bonefos, Didronel and Zometa are part of a drug category called bisphosphonates. These drugs have been increasingly linked to osteonecrosis, a serious disorder in which the bone...
The Medicines and Healthcare Products Regulatory Agency (MHRA) in the United Kingdom is the equivalent of the FDA in the U.S. A new study was reported by MHRA on March 1, 2006, regarding Celebrex. It lists a new study by several authors, including Dr. Brent Caldwell, citing a medical journal. The website summarized, stating the new study is based on data already assessed by regulatory agencies...
Merck & Co. has been playing fast and loose with the truth for years relating to its testing and marketing of Vioxx. Finally, in an admission that undermines its core defense in Vioxx-related lawsuits, Merck has finally decided to tell the truth. Merck now says it erred when it reported in early 2005 that a crucial statistical test showed that Vioxx caused heart problems only after 18 months of...
One of today's top Reuters headlines talks of a new barrage of Vioxx litigation over this defective drug that has been proven to cause strokes and heart attacks. Though a case in Texas was recently dropped by a plaintiff just two weeks before trial, several others move forward and will soon go to trial, including one in an Alabama state court. Drug manufacturer Merck & Co. is facing more than...
The 2004 approval of the antibiotic Ketek, is a "mistake," according to FDA safety official Dr. David Graham. Graham suggested immediate withdrawal of the controversial antibiotic, citing its toxicity and lack of adequate safety research. Over five million prescriptions have been written for Ketek, which has been linked to reports of liver damage, blurred vision, loss of consciousness, and death.
